홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

5-chloro-8-fluoro-3-[(4-methylphenyl)sulfonyl]pyrrolo[2',3':4,5]pyrimido[6,1-b]quinazolin-7(3H)-one → 5-{[1-(N,N-dimethylglycyl)-6-(ethyloxy)-1,2,3,4-tetrahydro-7-quinolinyl]amino}-8-fluoro-3-[(4-methylphenyl)sulfonyl]pyrrolo[2',3':4,5]pyrimido[6,1-b]quinazolin-7(3H)-one

HRID 1014461
노트
인쇄 미리보기

반응식

HRID 1014461 반응식
Cl[C:2]1[N:15]2[C:6](=[N:7][C:8]3[C:13]([C:14]2=[O:16])=[C:12]([F:17])[CH:11]=[CH:10][CH:9]=3)[C:5]2[CH:18]=[CH:19][N:20]([S:21]([C:24]3[CH:29]=[CH:28][C:27]([CH3:30])=[CH:26][CH:25]=3)(=[O:23])=[O:22])[C:4]=2[N:3]=1.[CH3:31][N:32]([CH2:34][C:35]([N:37]1[C:46]2[C:41](=[CH:42][C:43]([O:48][CH2:49][CH3:50])=[C:44]([NH2:47])[CH:45]=2)[CH2:40][CH2:39][CH2:38]1)=[O:36])[CH3:33]>O1CCCC1>[CH3:31][N:32]([CH3:33])[CH2:34][C:35]([N:37]1[C:46]2[C:41](=[CH:42][C:43]([O:48][CH2:49][CH3:50])=[C:44]([NH:47][C:2]3[N:15]4[C:6](=[N:7][C:8]5[C:13]([C:14]4=[O:16])=[C:12]([F:17])[CH:11]=[CH:10][CH:9]=5)[C:5]4[CH:18]=[CH:19][N:20]([S:21]([C:24]5[CH:25]=[CH:26][C:27]([CH3:30])=[CH:28][CH:29]=5)(=[O:23])=[O:22])[C:4]=4[N:3]=3)[CH:45]=2)[CH2:40][CH2:39][CH2:38]1)=[O:36]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 594416275-chloro-8-fluoro-3-[(4-methylphenyl)sulfonyl]pyrrolo[2',3':4,5]pyrimido[6,1-b]quinazolin-7(3H)-oneHCID 594421011-[(Dimethylamino)acetyl]-6-(ethyloxy)-1,2,3,4-tetrahydro-7-quinolinamine

생성물 1

HCID 673170085-{[1-(N,N-dimethylglycyl)-6-(ethyloxy)-1,2,3,4-tetrahydro-7-quinolinyl]amino}-8-fluoro-3-[(4-methylphenyl)sulfonyl]pyrrolo[2',3':4,5]pyrimido[6,1-b]quinazolin-7(3H)-one수율 69.8%

시약·촉매·용매 1

HCID 8028
Tetrahydrofuran
용매

반응 조건

온도
75 °C

실험 절차

A suspension of 5-chloro-8-fluoro-3-[(4-methylphenyl)sulfonyl]pyrrolo[2′,3′:4,5]pyrimido[6,1-b]quinazolin-7(3H)-one (550 mg, 1.147 mmol) and 1-[(dimethylamino)acetyl]-6-(ethyloxy)-1,2,3,4-tetrahydro-7-quinolinamine (318 mg, 1.147 mmol) in tetrahydrofuran (30 mL) was stirred at 75° C. in a pressure vessel for 16 hours. All volatiles were removed and the solids were partitioned between dichloromethane and saturated sodiuim bicarbonate. The organic layer was taken to a residue under reduced pressure and the derived solids were triturated with diethyl ether to afford 5-{[1-(N,N-dimethylglycyl)-6-(ethyloxy)-1,2,3,4-tetrahydro-7-quinolinyl]amino}-8-fluoro-3-[(4-methylphenyl)sulfonyl]pyrrolo[2′,3′:4,5]pyrimido[6,1-b]quinazolin-7(3H)-one (548 mg, 0.801 mmol, 69.8%) as a yellow solid. A solution of 5-{[1-(N,N-dimethylglycyl)-6-(ethyloxy)-1,2,3,4-tetrahydro-7-quinolinyl]amino}-8-fluoro-3-[(4-methylphenyl)sulfonyl]pyrrolo[2′,3′:4,5]pyrimido[6,1-b]quinazolin-7(3H)-one (0.548 g, 0.801 mmol) in tetrahydrofuran (50 ml) was treated with methylamine in THF (2.0M) (3.21 ml, 6.41 mmol) and stirred for 16 hours. Celite was added, all volatiles were removed under reduced pressure, and the residue was purified via column chromatography to afford 2-({2-{[1-(N,N-dimethylglycyl)-6-(ethyloxy)-1,2,3,4-tetrahydro-7-quinolinyl]amino}-7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)-6-fluoro-N-methylbenzamide (310 mg) The tosylate was dissolved in 1,4-dioxane (8 ml)/2.0N NaOH (aq) (8 ml), added to a microwave vial, and warmed under microwave heating at 120° C. for 12 minutes. The reaction was cooled, diluted with ethyl acetate/saturated sodium chloride (aq), and the organic layer was dried over sodium sulfate, filtered, stripped onto celite, and purified by column chromatography to afford 2-[(2-{[1-(N,N-dimethylglycyl)-6-(ethyloxy)-1,2,3,4-tetrahydro-7-quinolinyl]amino}-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-6-fluoro-N-methylbenzamide (0.110 g, 0.196 mmol, 24.48%) as a white solid. 1H NMR (400 MHz, DMSO-d6) δ ppm 11.37 (s, 1H), 10.10 (s, 1H), 8.47-8.57 (m, 1H), 8.42 (s, 1H), 8.24 (d, J=6.82 Hz, 1H), 7.45 (s, 1H), 7.30-7.42 (m, 1H), 6.99 (d, J=3.01 Hz, 1H), 6.89-6.98 (m, 1H), 6.81 (s, 1H), 6.29 (dd, J=3.41, 1.81 Hz, 1H), 4.03-4.17 (m, 2H), 3.70 (t, J=6.72 Hz, 2H), 3.20 (s, 2H), 2.79 (d, J=4.41 Hz, 3H), 2.61-2.70 (m, 2H), 2.09 (t, J=9.43 Hz, 6H), 1.77-1.92 (m, 2H), 1.37 (t, J=6.82 Hz, 3H). ESIMS (M+H)+=561.

후처리

  1. customAll volatiles were removed
  2. customthe solids were partitioned between dichloromethane and saturated sodiuim bicarbonate
  3. customthe derived solids were triturated with diethyl ether

출처 및 근거

ORD 기록
ord-1e57b62167144624aae1269963e1492b
출처 데이터셋
uspto-grants-2011_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07981903B2

반응 노트

불러오는 중…

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트